Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (24528) 24528
Journal Article (7133) 7133
Trade Publication Article (1948) 1948
Magazine Article (1792) 1792
Web Resource (329) 329
Newsletter (195) 195
Report (191) 191
Government Document (103) 103
Book / eBook (82) 82
Book Chapter (64) 64
Transcript (62) 62
Streaming Video (53) 53
Dissertation (44) 44
Book Review (21) 21
Paper (21) 21
Reference (19) 19
Conference Proceeding (15) 15
Publication (5) 5
Journal / eJournal (2) 2
Video Recording (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prescription drugs (26332) 26332
pharmaceutical industry (10043) 10043
fda approval (6977) 6977
medicare (6060) 6060
humans (4314) 4314
science & technology (4262) 4262
life sciences & biomedicine (4094) 4094
drug stores (3312) 3312
prescription drug plans (3175) 3175
patients (3038) 3038
earnings per share (3030) 3030
clinical trials (2994) 2994
medicare prescription drug improvement & modernization act 2003-us (2983) 2983
health care policy (2722) 2722
stockholders (2671) 2671
drugs (2496) 2496
net losses (2436) 2436
medicaid (2348) 2348
cost control (2273) 2273
pharmacy (2252) 2252
prescriptions (2123) 2123
generic drugs (2094) 2094
research & development--r&d (2067) 2067
drug dosages (1935) 1935
female (1890) 1890
health insurance (1855) 1855
male (1790) 1790
narcotics (1734) 1734
costs (1724) 1724
united states (1722) 1722
regulatory approval (1709) 1709
physicians (1682) 1682
investments (1634) 1634
studies (1620) 1620
biotechnology industry (1601) 1601
aged (1553) 1553
webcasting (1458) 1458
archives & records (1414) 1414
covid-19 (1410) 1410
pharmaceuticals (1405) 1405
prices (1363) 1363
prescribing (1318) 1318
insurance coverage (1304) 1304
pharmacists (1291) 1291
marketing (1287) 1287
hospitals (1236) 1236
health care (1216) 1216
middle aged (1205) 1205
stock exchanges (1205) 1205
pain (1191) 1191
pharmacy benefit management (1176) 1176
coronaviruses (1168) 1168
financial performance (1151) 1151
fees & charges (1131) 1131
health care expenditures (1118) 1118
older people (1100) 1100
adult (1071) 1071
corporate profits (1065) 1065
product development (1051) 1051
collaboration (1038) 1038
health care sciences & services (1020) 1020
drug therapy (1011) 1011
medical research (1011) 1011
diabetes (1005) 1005
general & internal medicine (996) 996
medicine, general & internal (981) 981
public health (975) 975
cancer therapies (927) 927
medicine (918) 918
prescription writing (897) 897
laws, regulations and rules (893) 893
beneficiaries (883) 883
chief executive officers (849) 849
pediatrics (849) 849
web sites (841) 841
abridged index medicus (838) 838
oncology (836) 836
analysis (833) 833
prescription fees (829) 829
cancer (795) 795
disease (793) 793
pharmacology & pharmacy (776) 776
drug prescriptions (775) 775
research (772) 772
health policy & services (764) 764
agreements (756) 756
medical sciences (751) 751
bills (748) 748
biological and medical sciences (746) 746
acquisitions & mergers (717) 717
user fees (707) 707
administrative expenses (697) 697
dermatology (645) 645
biological products (644) 644
business metrics (634) 634
legislation (627) 627
metastasis (619) 619
candidates (607) 607
social sciences (590) 590
care and treatment (589) 589
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (53) 53
Robarts - Stacks (12) 12
Gerstein Science - Stacks (10) 10
Law (Bora Laskin) - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
UofT at Mississauga - Stacks (4) 4
New College (Ivey) - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Bindery (2) 2
Gerstein Science - Periodical Stacks (2) 2
Media Commons - Audio Visual (2) 2
Robarts - Government Pubs (2) 2
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
New College (Ivey) - Reserve desk (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36491) 36491
French (58) 58
Spanish (36) 36
German (25) 25
Japanese (23) 23
Portuguese (16) 16
Swedish (8) 8
Polish (5) 5
Chinese (4) 4
Korean (4) 4
Norwegian (4) 4
Dutch (3) 3
Italian (3) 3
Russian (2) 2
Czech (1) 1
Estonian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
Urdu (1) 1
Zulu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Impact of providing fee data on laboratory test ordering: A controlled clinical trial
by Feldman, Leonard S and Shihab, Hasan M and Thiemann, David and Yeh, Hsin-Chieh and Ardolino, Margaret and Mandell, Steven and Brotman, Daniel J
JAMA internal medicine, ISSN 2168-6106, 05/2013, Volume 173, Issue 10, pp. 903 - 908
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clinical Laboratory Techniques - statistics & numerical data | Practice Patterns, Physicians' - economics | Fees and Charges | Medicare | United States | Humans | Middle Aged | Male | Prescriptions - statistics & numerical data | Practice Patterns, Physicians' - statistics & numerical data | Prescriptions - economics | Baltimore | Diagnostic Tests, Routine - economics | Hospitals - statistics & numerical data | Cost Control | Adult | Female | Aged | Data Display | Diagnostic Tests, Routine - statistics & numerical data | Clinical Laboratory Techniques - economics
Journal Article
Details down arrow
2. Full Text Controversy still swirls around FDA user fees: Since 1992, the prescription drug user fee act and reauthorizations have sped up new drug approvals—but does speed equal safety?
by Ullman, Kurt
Annals of neurology, ISSN 0364-5134, 11/2013, Volume 74, Issue 5, pp. A10 - A11
Prescription Drugs - economics | Drug Approval - economics | United States | Humans | United States Food and Drug Administration - economics | Drug Approval - legislation & jurisprudence | United States Food and Drug Administration - legislation & jurisprudence | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Drug user fees
: enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007
United States. Congress.Senate.Committee on Health, Education, Labor, and Pensions
2008, S. hrg., ISBN 9780160817595, Volume 110-384
Drugs | United States. Food and Drug Administration | User charges | United States | Safety measures | Testing
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The effect of user fees on prescribing quality in rural Nepal: two controlled pre‐post studies to compare a fee per drug unit vs. a fee per drug item
by Holloway, Kathleen A and Karkee, Shiva and Tamang, Ashalal and Gurung, Yam Bahadur and Pradhan, Ramesh and Reeves, Barnaby C
Tropical medicine & international health, ISSN 1360-2276, 04/2008, Volume 13, Issue 4, pp. 541 - 547
evaluation | precio al usuario | évaluation | redevance | developing countries | calidad de la prescripción | user fees | prescribing quality | evaluación | qualité des prescriptions | pays en développement | países en vías de desarrollo | Developing countries | Evaluation | Prescribing quality | User fees | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Tropical Medicine | Biological and medical sciences | General aspects | Medical sciences | Financing, Personal - economics | Pharmaceutical Preparations - economics | Drug Prescriptions - economics | Guideline Adherence | Prospective Studies | Humans | Practice Patterns, Physicians | Rural Health | Nepal | Prescription Fees | Quality of Health Care | Rural Health Services | Prescription writing | Health economics | Rural areas | Prescriptions | Drug use | Quality of care | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Maine pharmacists eye legislation to end drug plans’ retroactive fees
by Traynor, Kate
American journal of health-system pharmacy, ISSN 1079-2082, 04/2017, Volume 74, Issue 7, pp. 455 - 456
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Laws, regulations and rules | Medical fees | Practice | Compensation and benefits | Research | Pharmacists | Prescription drug plans | Legislation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Reasonable Rx
: solving the drug price crisis
by Finkelstein, Stan N
2008, ISBN 9780132344494, xvi, 188
Book
Details down arrow
7. Full Text Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation
by Williams, Andrew James and Henley, William and Frank, John
BMJ open, ISSN 2044-6055, 12/2018, Volume 8, Issue 12, pp. e021318 - e021318
interrupted time series | natural experiment | administrative data | quasi-experimental | co-payment | fees, pharmaceutical | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glucocorticoids - therapeutic use | Interrupted Time Series Analysis | Humans | Middle Aged | Scotland - epidemiology | Asthma - drug therapy | Pulmonary Disease, Chronic Obstructive - epidemiology | Prescription Fees | Young Adult | Drug Prescriptions - statistics & numerical data | Drug Prescriptions - economics | Glucocorticoids - economics | Universal Health Insurance | Adolescent | Adult | Patient Admission - statistics & numerical data | Retrospective Studies | Asthma - epidemiology | Databases, Factual | Pulmonary Disease, Chronic Obstructive - drug therapy | Fees & charges | Parameter estimation | Medical technology | Heart attacks | Time series | Big Data | Insurance coverage | Patient admissions | Generalized linear models | Asthma | Hospitals | Socioeconomic factors | Chronic obstructive pulmonary disease | Diabetes | Prescriptions | Drug stores | Public health | Ambulatory care | Chronic illnesses | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Driving down the cost of drugs
: battling big pharma in the statehouse
by Castellblanch, Ramón, 1948
2012, ISBN 1935049453, xi, 173
Drugs | Prices | Prescription pricing
Book
Details down arrow
9. Full Text Medicare advantage enrollees more likely to enter lower- quality nursing homes compared to fee-for-service enrollees
by Meyers, David J and Mor, Vincent and Rahman, Momotazur
Health Affairs, ISSN 0278-2715, 01/2018, Volume 37, Issue 1, pp. 78 - 85
Medicare | Insurance | Long-term care | Quality of care | Managed care - Medicare < managed care | Health Care Sciences & Services | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Nursing Homes - standards | Patient Readmission | United States | Humans | Medicare - statistics & numerical data | Aged, 80 and over | Medicare Part C - statistics & numerical data | Aged | Quality Indicators, Health Care - statistics & numerical data | Nursing Homes - statistics & numerical data | Databases, Factual | Medicare Part C - standards | Health care | Nursing homes | Networks | Costs | Patients | Datasets | Studies | Residential areas | Demographics | Nursing | Medicare Prescription Drug Improvement & Modernization Act 2003-US | Government programs | Ratings & rankings | Medicaid | Beneficiaries | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Speed, Safety, and Industry Funding — From PDUFA I to PDUFA VI
by Darrow, Jonathan J and Avorn, Jerry and Kesselheim, Aaron S
The New England journal of medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 23, pp. 2278 - 2286
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Studies | Fees & charges | Prescription drugs | User fees | Biological products | Funding | Clinical trials | Federal legislation | FDA approval | Pharmaceutical industry | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. The big fix
: how the pharmaceutical industry rips off American consumers
by Greider, Katharine
2003, 1st ed., ISBN 9781586481858, xvi, 189
Drugs | Corrupt practices | Prices | Price fixing | Prescription pricing | Pharmaceutical industry
Book
Details down arrow
12. Full Text Less intense postacute care, better outcomes for enrollees in medicare advantage than those in fee-for-service
by Huckfeldt, Peter J and Escarce, José J and Rabideau, Brendan and Karaca-Mandic, Pinar and Sood, Neeraj
Health Affairs, ISSN 0278-2715, 2017, Volume 36, Issue 1, pp. 91 - 100
Health Care Sciences & Services | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Heart Failure - rehabilitation | Subacute Care - methods | Patient Readmission | Fee-for-Service Plans - statistics & numerical data | United States | Health Expenditures - statistics & numerical data | Humans | Male | Medicare Part C - statistics & numerical data | Medicare Part C - economics | Arthroplasty, Replacement - statistics & numerical data | Fee-for-Service Plans - economics | Arthroplasty, Replacement - rehabilitation | Subacute Care - economics | Aged, 80 and over | Female | Aged | Outcome Assessment, Health Care | Stroke - therapy | Health care | Heart | Incentives | Subacute care | Payments | Long term health care | Clinical outcomes | Prospective payment systems | Reimbursement | Monetary incentives | Heart diseases | Beneficiaries | Public health | Heart failure | Accountable care organizations | Stroke | Medicare | Payment systems | Health care policy | Patients | Discharge | Nursing | Medicare Prescription Drug Improvement & Modernization Act 2003-US | Government programs | Diagnosis related groups--DRGs | Internet | Rehabilitation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
by Lloyd, Jennifer T and Maresh, Sha and Powers, Christopher A and Shrank, William H and Alley, Dawn E
Medical care, ISSN 0025-7079, 03/2019, Volume 57, Issue 3, pp. 218 - 224
healthy adherer bias | prescription drugs | drug policy | adherence | cost effectiveness | Health Care Sciences & Services | Public, Environmental & Occupational Health | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Hypertension | Medical care | Care and treatment | Patient compliance | Analysis | Health care | Heart failure | Heart | Drugs | Medicare | Hyperlipidemia | Diabetes mellitus | Health services utilization | Health care policy | Estimates | Chronic conditions | Government programs | Expenditures | Research design | Diabetes | Heart diseases | Emergency medical services
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK
by Doble, Brett and Payne, Rupert and Harshfield, Amelia and Wilson, Edward C F
BMJ open, ISSN 2044-6055, 12/2017, Volume 7, Issue 12, pp. e019382 - e019382
primary care | therapeutics | health policy | health economics | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypertension | Fees & charges | Computerized physician order entry | Health services | Health care policy | Glucose | Patients | Primary care | Cost control | Prescription drugs | Antidepressants | Diuretics | Diabetes | Clinical medicine | Cost analysis | Medicaid | Drug therapy | Ambulatory care | Chronic illnesses | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections
by Muraki, Yuichi and Kusama, Yoshiki and Tanabe, Masaki and Hayakawa, Kayoko and Gu, Yoshiaki and Ishikane, Masahiro and Yamasaki, Daisuke and Yagi, Tetsuya and Ohmagari, Norio
BMC health services research, ISSN 1472-6963, 05/2020, Volume 20, Issue 1, pp. 399 - 399
Life Sciences & Biomedicine | Health Care Sciences & Services | Science & Technology | Health facilities | Pediatrics | Antibiotics | Antimicrobial agents | Drug resistance | Prescriptions | Patients | Age groups | Index Medicus | Antimicrobial stewardship | Fees and charges | Antimicrobial resistance | Upper respiratory tract infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Drug-Review Deadlines and Safety Problems
by Carpenter, Daniel and Zucker, Evan James and Avorn, Jerry
The New England journal of medicine, ISSN 0028-4793, 03/2008, Volume 358, Issue 13, pp. 1354 - 1361
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Drug Labeling | Time Factors | Drug Approval - methods | United States | Drug Industry - economics | Drug Industry - legislation & jurisprudence | Drug-Related Side Effects and Adverse Reactions | Government Regulation | Product Surveillance, Postmarketing | Drug Approval - legislation & jurisprudence | United States Food and Drug Administration - legislation & jurisprudence | Drug and Narcotic Control - statistics & numerical data | Evaluation | Laws, regulations and rules | Drug approval | Fees & charges | Prescription drugs | Deadlines | FDA approval | Pharmaceutical industry | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights